Compare Novavax Inc (NVAX) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs VF Corp — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while VF Corp trades at $16.88 (market cap $6.62B). The key difference: VF Corp is far larger — about 5.1× Novavax Inc's market cap, and VF Corp pays a 2.13% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | VFC | |
|---|---|---|
Market Cap | $1.30B | $6.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $21.55 |
52-Week Low | $6.22 | $11.66 |
Enterprise Value | $800.50M | $10.77B |
Dividend Yield | — | 2.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
